← Evidence map

ReviewMolecular oncology2012

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.

Rodrigo Dienstmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22189054